Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

UBS AG (AMUB) Form 424B3 — Aug 18, 2026

$AMUBForm 424B3Filed Aug 18, 2026, 2:58 PM ET0001839882-26-040423Original filing

UBS AG filed Amendment No. 1 to the pricing supplement for $10,255,000 of Trigger Autocallable Contingent Yield Notes with Memory Interest, issued by UBS AG London Branch and linked to the common stock of Boston Scientific Corporation (BSX). The notes settle August 19, 2026, with a final valuation date of August 14, 2029 and maturity on August 17, 2029. The notes pay a 10.59% per annum contingent coupon ($26.475 per quarter per $1,000 note) whenever BSX closes at or above the $28.51 coupon barrier, equal to 55% of the $51.83 initial level.

Key figures

Debt Amount
10255000
Interest Rate
10.59% per annum (contingent coupon rate)
Maturity Date
2029-08-17
Gross Proceeds
10255000
Offering Price
$1,000 per note
Isin
US90265WLL27
Term
Approximately 3 years
Cusip
90265WLL2
Trade Date
2026-08-14
Notes Count
10255
Coupon Barrier
$28.51 (55.00% of initial level)
Settlement Date
2026-08-19
Proceeds To Issuer
$9,998,625
Downside Threshold
$28.51 (55.00% of initial level)
Call Threshold Level
$51.83 (100.00% of initial level)
Final Valuation Date
2029-08-14
Underlying Initial Level
$51.83
Underwriting Discount Total
$256,375
Underwriting Discount Per Note
$25.00
Estimated Initial Value Per Note
$966.20
First Potential Call Settlement Date
2027-02-19
Contingent Coupon Per Quarter Per Note
$26.475

AI analysis

Red flags6 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.